ITNS 0.00 Itonis, Inc.
| Range: | 1.9E-4-0.0013 | Vol Avg: | 954540 | Last Div: | 0 | Changes: | 0 |
| Beta: | 0.07 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Feb 21 2007 | Empoloyees: | 3 | ||
| CUSIP: | 465733103 | CIK: | ISIN: | US4657331033 | Country: | US | |
| CEO: | Mr. Mark H. Cheung | Website: | https://www.itonisholdings.com | ||||
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow